DYN FY 2021 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$150M

Net Income

-$149M

EPS (Diluted)

$-2.93

Cash Flow

Operating Cash Flow

-$120M

Free Cash Flow

-$123M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$426M

Total Liabilities

$57M

Stockholders' Equity

$368M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$700,000	+100.0%
Operating Income	-$150M	-$59M	-155.8%
Net Income	-$149M	-$59M	-154.2%